Hedgehog Signaling: From Basic Biology to Cancer Therapy

Area of Science:

• Molecular Biology
• Oncology
• Drug Discovery

Background:

• The Hedgehog (HH) signaling pathway is fundamental in embryonic development.
• Aberrant HH pathway activation is implicated in various human cancers.
• HH signaling represents a promising therapeutic target for cancer treatment.

Purpose of the Study:

• To provide an overview of HH signaling.
• To summarize small molecules that modulate HH signaling.
• To discuss challenges and lessons learned in developing HH-targeted cancer therapies.

Main Methods:

• Literature review of HH signaling pathway.
• Summary of endogenous and exogenous small molecules targeting HH.
• Analysis of clinical development of HH-targeted cancer therapies.

Main Results:

• HH pathway deregulation is a significant driver in numerous cancers.
• Various small molecules have been developed to modulate HH signaling.
• Decades of research have yielded insights but also revealed challenges in HH-targeted therapy.

Conclusions:

• HH signaling remains a critical area for cancer research and therapeutic development.
• Further research is needed to overcome challenges in developing next-generation HH-targeted cancer therapies.